RNA Therapy Targets Permanent HIV Silencing
By leveraging the Buffalo Niagara Medical Campus as a primary site for clinical trials, the region can transition from a regional hub for chronic disease maintenance to a high-value epicenter for next-generation genetic therapeutics.
Read More